EMA and MHA organise workshop on availability of medicines in the EU
30 August 2018
On 8-9 November 2018, a task force set up by the European Medicines Agency ("EMA") and the Heads of Medicines Agencies (HMA) hosts a workshop where stakeholders in the pharmaceutical industry are invited to share their suggestions on how to improve availability of medicines in the EU.
Further, the workshop is also intended to provide a platform for co-operation between the Member States, EMA and the European Commission on the handling of a potential shortages of medicines in the EU in consequence of the United Kingdom's withdrawal from the EU.
You can read more about the workshop and the recently published work programme of the task force here
